USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Revogenex Ireland Ltd

USPTO PatentsView assignee record - 17 granted patents across 2 technology areas, recorded in grant years 2017–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

RSS updates for this company

The verdict

According to USPTO PatentsView, Revogenex ranks #17,123 of 49,997 tracked US assignees by granted-patent volume, with 17 patents across 2 technology areas.

#17,123
of 49,997 US assignees by volume
18th percentile
by Innovation Score (25.8/100)
18.0
avg claims per patent
+13%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R17123 · Foreign Corporation #17,123 · 17 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-UP · BOOK-FULL

  • GRANTS-MICRO 17 grants
  • MID-PACK #17,123/49,997
  • PHOTO-FINISH Refocus Group
  • CPC-NARROW A61K · 2 areas
  • INNOV-THIN 25.8/100
  • CLAIMS-RICH 18.0 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-UP +13% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Refocus Group, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Revogenex’s 25.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Revogenex

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Revogenex's Innovation Score is 25.8/100 (18th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Revogenex?

Each dot is one of Revogenex’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Revogenex’s own 18.0 claims/patent is ABOVE the 16.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Revogenex vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 16.916.91717.1 510152025 Granted patents (volume) Avg claims / patent Refocus Group, Inc. - 17, 20.76Refocus GroupReinke Manufacturing Company, Inc. - 17, 15Reinke Manufactur…Relay, Inc. - 17, 20.06RelayReliance Medical Products - 17, 6.47Reliance Medical…RiskIQ, Inc. - 17, 20.82RiskiqRocket Innovations, Inc. - 17, 19.65Rocket InnovationsRockline Industries, Inc. - 17, 6.71Rockline Industri…Rockwell Automation Switzerland GmbH - 17, 16.59Rockwell Automati…Revogenex Ireland Ltd - 17, 18Revogenex Ireland
Revogenex vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Revogenex's grants concentrate

Revogenex Ireland Ltd is a focused PatentsView assignee: 2 CPC subclasses with 100% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2020 (9 grants) versus a trough of 1 in 2019. By volume, Revogenex sits between Refocus Group, Inc. and Rockwell Automation Switzerland GmbH.

Who files at Revogenex's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Revogenex holds 17 patents at rank #17,128, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Revogenex

By rank, the assignees closest to #17,128 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Revogenex's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Revogenex, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Revogenex ranks #1,331 of 7,163 assignees by patent count in that subclass.

Revogenex's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

26 18th percentile higher than 18% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0246810 2017201820192020 9
USPTO utility patent grants by year · 2017–2020

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table
Revogenex Ireland Ltd patent grants by year, 2015–2025
Year Patents Granted Share of Period
2017 3 17.6%
2018 4 23.5%
2019 1 5.9%
2020 9 52.9%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Revogenex Ireland Ltd's patent record in context - here's where to go next.

  • Revogenex Ireland Ltd's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 100% of its portfolio - see every assignee active in that class. Explore A61K
  • Ranked #17,123 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Revogenex Ireland Ltd against Refocus Group, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 25.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.